Texas State Board Of Pharmacy Collaborative Practice Agreement

This article has highlighted contemporary jurisprudence, regulatory and legal trends that affect the field of professional treatment of pharmacists. Monitoring opioid use, preventing medication errors, and alerting advice/reporting illustrate the new or emerging legal risks associated with expanding professional practices. In the past, courts have consistently held that the responsibility for warning patients of possible side effects remains with the physician. Courts have often used legal education to exclude pharmacists from the obligation to measure. illustrates the additional responsibility that the profession assumes when it draws attention to its increased knowledge and technical skills. In this case, Arbor Drugs developed its pharmacy system to help the pharmacist monitor patient profiles and detect serious drug interactions. The pharmacist filled new prescriptions for a patient; One of these drugs had a significant interaction with the patient`s current medications. The pharmacist did not warn the patient of the possible interaction. The Centers for Disease Control and Prevention (CDC) estimates that in 2010, the volume of opioids prescribed reached the level of drug treatment of every American 24 hours a day for a month.2 Combating the opioid overdose epidemic is a priority for drug enforcement, cdc, and BOPs.

The Controlled Substances Act (CSA) states that a prescription for a controlled substance can only be issued for legitimate medical use by a registered physician.. . . .

Comments are closed.